Purchase Order 75N93023P01354
Award Date
9/20/23
Potential Completion Date
12/29/23
Potential Value
$25K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Biolegend, Inc.
Ultimate Awardee
Revvity Inc.
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $8,377.50 to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the delivery of "Brilliant Violet Anti-Human Antibodies" to support the agency's research efforts. Biolegend, Inc. is a subsidiary of the parent company Revvity Inc. This contract...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $21,863.25 to Biolegend, Inc. for BIOLEGEND TOTALSEQ ANTIBODIES. No set-aside designation was used. Performance will occur in San Diego, California with a completion date of May 7, 2024. Biolegend, Inc. is a subsidiary of Revvity Inc.'s Medical Imaging, LLC division. The award is likely associated with research efforts...
Biolegend, Inc. has been awarded a firm fixed price purchase order contract valued at twenty-four thousand five hundred sixty-one dollars and seventy-five cents ($24,561.75) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of BIOLEGEND ANTIBODIES with performance through September 30, 2023. As a manufacturer of biomedical reagents, antibodies, proteins, and other products to...
This firm-fixed-price federal purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical products. The $31,957.50 contract supports the supply of various antibodies, reagents, and kits to advance research initiatives across NIAID, with no set-aside designation. Biolegend has a long history of providing specialized products for...
This firm-fixed-price federal contract award, valued at $25,200.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the prime contractor Biolegend, Inc. The contract is for the provision of 144 units of Brilliant Violet 421 Anti-Human CD4 reagents, which are used to support biomedical research efforts across multiple federal agencies. Biolegend is a for-profit manufacturer and supplier of specialized...
This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The $9,550.00 firm-fixed-price contract is for the provision of Brilliant Violet 605 Anti-Human IL-17A reagents to support research...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $29,645.10 firm fixed price purchase order to Biolegend, Inc. for BIOLEGEND REAGENTS. Biolegend, Inc. is a subsidiary of Revvity Inc. Medical Imaging, LLC. The place of performance will be Biolegend's facilities located in San Diego, California. The period of performance is from June 27, 2023 through September 30, 2023. No additional details were provided regarding subcontractors or the NIH...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...